4//SEC Filing
Finn John 4
Accession 0001181431-13-023616
CIK 0001356857other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 2:40 PM ET
Size
5.2 KB
Accession
0001181431-13-023616
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-04-24$7.10/sh−500$3,550→ 189,860 total(indirect: By Trust)
Holdings
- 1,782
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeother
Related Parties
1- filerCIK 0001479788
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 2:40 PM ET
- Size
- 5.2 KB